Nanjiang Zhou

2.0k total citations
24 papers, 1.7k citations indexed

About

Nanjiang Zhou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nanjiang Zhou has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nanjiang Zhou's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (5 papers). Nanjiang Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (5 papers). Nanjiang Zhou collaborates with scholars based in China, United States and Canada. Nanjiang Zhou's co-authors include Jianguo Huang, Yin‐Yuan Mo, Kounosuke Watabe, Ali Zhang, Fangting Wu, Qian Liu, Ziqiang Zhang, Y-Y Mo, Tsui-Ting Ho and Meng Xu and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Scientific Reports.

In The Last Decade

Nanjiang Zhou

22 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanjiang Zhou China 14 1.4k 1.3k 105 96 71 24 1.7k
Shengbo Han China 20 676 0.5× 400 0.3× 55 0.5× 91 0.9× 206 2.9× 34 1.2k
Yungui Wang China 18 929 0.7× 556 0.4× 52 0.5× 35 0.4× 112 1.6× 63 1.3k
Changsong Zhang China 16 446 0.3× 169 0.1× 69 0.7× 88 0.9× 169 2.4× 48 718
Agata Chrzanowska Australia 8 409 0.3× 352 0.3× 60 0.6× 74 0.8× 49 0.7× 19 657
Yujie Shen China 14 335 0.2× 148 0.1× 61 0.6× 111 1.2× 59 0.8× 50 630
Dragana Kastratović Serbia 8 549 0.4× 537 0.4× 32 0.3× 30 0.3× 41 0.6× 39 938
Ashley Gray United States 12 252 0.2× 128 0.1× 50 0.5× 68 0.7× 47 0.7× 32 645
Chong Qiao China 18 275 0.2× 144 0.1× 29 0.3× 43 0.4× 42 0.6× 73 776
Edward A. Meister United States 14 266 0.2× 158 0.1× 85 0.8× 22 0.2× 52 0.7× 27 607
Sarah Tremblay Canada 10 300 0.2× 152 0.1× 38 0.4× 25 0.3× 111 1.6× 16 523

Countries citing papers authored by Nanjiang Zhou

Since Specialization
Citations

This map shows the geographic impact of Nanjiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanjiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanjiang Zhou more than expected).

Fields of papers citing papers by Nanjiang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanjiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanjiang Zhou. The network helps show where Nanjiang Zhou may publish in the future.

Co-authorship network of co-authors of Nanjiang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Nanjiang Zhou. A scholar is included among the top collaborators of Nanjiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanjiang Zhou. Nanjiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yu, et al.. (2025). TFR1 as a Biomarker of Pulmonary Fibrosis Development in COPD Patients. International Journal of COPD. Volume 20. 2715–2725.
2.
You, Baiyang, Jie Zhang, Yaoshan Dun, et al.. (2025). Salidroside protects against myocardial infarction via activating MIF-mediated mitochondrial quality control. Chinese Medicine. 20(1). 27–27.
3.
Zhou, Nanjiang, Jeffrey W. Ripley-Gonzalez, Baiyang You, et al.. (2024). Preoperative exercise training decreases complications of minimally invasive lung cancer surgery: A randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery. 169(2). 516–528.e10. 3 indexed citations
4.
Ripley-Gonzalez, Jeffrey W., Nanjiang Zhou, Baiyang You, et al.. (2023). The long-term impact of the COVID-19 pandemic on physical fitness in young adults: a historical control study. Scientific Reports. 13(1). 15430–15430. 13 indexed citations
5.
Dun, Yaoshan, Shaoping Wu, Jeffrey W. Ripley-Gonzalez, et al.. (2023). Cardiorespiratory fitness and morbidity and mortality in patients with non-small cell lung cancer: a prospective study with propensity score weighting. Annals of Medicine. 55(2). 2295981–2295981. 4 indexed citations
6.
Dun, Yaoshan, Peng Hu, Jeffrey W. Ripley-Gonzalez, et al.. (2022). Effectiveness of a multicomponent exercise program to reverse pre-frailty in community-dwelling Chinese older adults: a randomised controlled trial. Age and Ageing. 51(3). 26 indexed citations
7.
Dun, Yaoshan, Jeffrey W. Ripley-Gonzalez, Nanjiang Zhou, et al.. (2021). Weight gain in Chinese youth during a 4-month COVID-19 lockdown: a retrospective observational study. BMJ Open. 11(7). e052451–e052451. 35 indexed citations
8.
Dun, Yaoshan, Jeffrey W. Ripley-Gonzalez, Nanjiang Zhou, et al.. (2021). The association between prior physical fitness and depression in young adults during the COVID-19 pandemic—a cross-sectional, retrospective study. PeerJ. 9. e11091–e11091. 13 indexed citations
9.
Dun, Yaoshan, Thomas P. Olson, Jeffrey W. Ripley-Gonzalez, et al.. (2021). Safety of Exercise Testing in the Clinical Chinese Population. Frontiers in Cardiovascular Medicine. 8. 638682–638682. 7 indexed citations
10.
Dun, Yaoshan, Shaoping Wu, Randal J. Thomas, et al.. (2021). Screening for Asymptomatic Coronary Artery Disease via Exercise Stress Testing in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 770648–770648. 2 indexed citations
11.
Dun, Yaoshan, Chao Liu, Jeffrey W. Ripley-Gonzalez, et al.. (2021). Six-month outcomes and effect of pulmonary rehabilitation among patients hospitalized with COVID-19: a retrospective cohort study. Annals of Medicine. 53(1). 2099–2109. 14 indexed citations
12.
Yao, Hongliang, Yu Wen, Hua Zhao, et al.. (2018). Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2871–2880. 59 indexed citations
13.
Chen, Weidong, Sanlin Lei, Li Xiong, et al.. (2017). Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line. Cell Death and Disease. 8(10). e3096–e3096. 36 indexed citations
14.
Singh, Ramesh, Shrish C. Gupta, Nanjiang Zhou, et al.. (2016). Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death and Disease. 7(6). e2262–e2262. 126 indexed citations
15.
Ho, Tsui-Ting, Jianguo Huang, Nanjiang Zhou, et al.. (2016). Regulation of PCGEM1 by p54/nrb in prostate cancer. Scientific Reports. 6(1). 34529–34529. 42 indexed citations
16.
Huang, Jianguo, Ali Zhang, Tsui-Ting Ho, et al.. (2015). Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Research. 44(7). 3059–3069. 100 indexed citations
17.
Huang, Jianguo, Nanjiang Zhou, Kounosuke Watabe, et al.. (2014). Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death and Disease. 5(1). e1008–e1008. 316 indexed citations
18.
Ho, Tsui-Ting, Nanjiang Zhou, Jianguo Huang, et al.. (2014). Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Research. 43(3). e17–e17. 200 indexed citations
19.
Liu, Qian, Jianguo Huang, Nanjiang Zhou, et al.. (2013). LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Research. 41(9). 4976–4987. 333 indexed citations
20.
Zhang, Ali, Nanjiang Zhou, Jianguo Huang, et al.. (2012). The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Research. 23(3). 340–350. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengbo Han Breakdown of academic impact, for papers by Yungui Wang Breakdown of academic impact, for papers by Changsong Zhang Breakdown of academic impact, for papers by Agata Chrzanowska Breakdown of academic impact, for papers by Yujie Shen Breakdown of academic impact, for papers by Dragana Kastratović Breakdown of academic impact, for papers by Ashley Gray Breakdown of academic impact, for papers by Chong Qiao Breakdown of academic impact, for papers by Edward A. Meister Breakdown of academic impact, for papers by Sarah Tremblay
Rankless by CCL
2026